How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →

National Cancer Institute researchers show 6-base sequencing has the potential to transform liquid biopsy utility in informing clinical decisions without parallel tissue samples

calendar_today February 27, 2026 person Tom Charlesworth domain biomodal

6-base ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumour transcription and resistance phenotypes in metastatic prostate cancer